Skip to search formSkip to main contentSkip to account menu

BCLC Stage B Adult Hepatocellular Carcinoma

Known as: Barcelona Clinic Liver Cancer Stage B Adult Hepatocellular Carcinoma 
Intermediate hepatocellular carcinoma. Patients may benefit from chemoembolization. (HPB (Oxford) 2005; 7(1):35-41)
National Institutes of Health

Related topics

Related topics

24 relations
Abdominal PainAberrant DNA MethylationBCLC StageBile Ducts, Extrahepatic

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
3:36 PM Abstract No. 37 Retrospective analysis of 30-60μm and 50-100μm HepaSphere drug-eluting beads doxorubicin (DEBDOX) embolization in BCLC B patients with non-resectable hepatocellular carcinoma…
2018
2018
Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations
Management of hepatocellular carcinoma (HCC) is framed within standardized protocols released by Scientific Societies, whose… 
2017
2017
Transarterial chemoembolization with or without microwave ablation in the treatment of intermediate (BCLC B) hepatocellular carcinoma.
e15635Background: Transarterial chemoembolization (TACE) is currently the first-line treatment for patients with intermediate… 
2017
2017
Microwave-assisted liver resection is safe and effective for selecting patients with BCLC stage B hepatocellular carcinoma
This study aimed to evaluate the feasibility and effectiveness of microwave ablation-assisted liver resection (MW-LR) and clamp… 
2017
2017
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
The SHARP study in 2007 [1] and the Asia Pacific study in 2008 [2] led to the worldwide approval of sorafenib as the standard… 
2016
2016
Radiofrequency Ablation following Transarterial Chemoembolization for Patients with BCLC B, C stage Hepatocellular Carcinoma
Poster: "ECR 2016 / C-0067 / Radiofrequency Ablation following Transarterial Chemoembolization for Patients with BCLC B, C stage… 
2015
2015
[Analysis of risk factors of recurrence in patients with BCLC 0-A hepatocellular carcinoma after surgical resection].
OBJECTIVE To analyze the risk factors of recurrence in patients with Barcelona Clinic Liver Cancer (BCLC) 0-A hepatocellular… 
2014
2014
Treatment efficacy and prognostic factors for huge HCC based on Barcelona Clinic Liver Cancer staging.
OBJECTIVE To explore the most appropriate treatment for patients with hepatocellular cancer (HCC)>10 cm by using the Barcelona… 
2014
2014
Survival analysis of proposed BCLC B subgroups in hepatocellular carcinoma patients
Review
2014
Review
2014
Author's response to reviews Title:Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate…
Title:Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)